Category : Public Health, Disease Prevention & Wellness

Findings from the first prospective validation trial for biomarker presented at ASTRO 2025 Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, announced that new data...

EPA registration paves the way for beekeepers to combat a critical threat to pollinator health GreenLight Biosciences (“the Company” or “GreenLight Bio”) today announced the...

– Partner Curasense will market Equazen® products featuring a clinically researched combination of essential fatty acids across pharmacies, healthcare stores and online pharmacies. SFI Health™ EMEA, the...

The collaboration will seek to foster the adoption of appropriate protocols and pathways for the integration of ENBUMYST™ (bumetanide nasal spray) into clinical care with the goal...

Following Gov. Newsom’s declaration of a State of Emergency in Tuolumne County, Health Net, one of California’s most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), is...

BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) announced today that the Therapeutic Goods Administration (TGA) of Australia has approved lecanemab (Leqembi) for the treatment of adult patients with mild...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced...

Unified Brand and Lucet™ at Home Reflects the Integration of Lucet and Emcara Health and a Shared Commitment to Expanding Access and Improving Clinical Outcomes. Lucet,...

Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opzelura® (ruxolitinib) cream 1.5%, a topical Janus kinase (JAK) inhibitor, for...